🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsGeneric oral semaglutide — 12 month update Page 2

Generic oral semaglutide — 12 month update

TrialNerd_Beth Mon, Feb 2, 2026 at 11:34 PM 24 replies 1,302 viewsPage 2 of 5
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Feb 3, 2026 at 4:53 AM#6
amsterdam_pete said:
The OASIS programme put 50mg oral in the same territory as 2.4mg injectable — around 15% mean weight loss — but it needed a dose 20 times larger to…

I do not accept that the fasting window is a minor inconvenience. Adherence data on daily orals with timing requirements is consistently worse than weekly injections, and a drug you take imperfectly is a lower dose than the one on the box.

Worth separating that from semaglutide, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

28 23josh_phd_bmore, roxy_nash, tony_orlando and 25 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Feb 3, 2026 at 6:58 AM#7

Adding the numbers, since they settle part of this. For anyone assembling their own picture: Tmax is one to three days, terminal half-life about 165 to 170 hours, steady state at four to five weeks, and subcutaneous bioavailability near 89%. Those four numbers explain most of the questions people ask about timing.

Worth separating that from semaglutide, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

27 22stefan_berlin, Dr.EM_Chicago, pete_RVA and 24 others
Reply Quote Save Share Report
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
Feb 3, 2026 at 9:03 AM#8
sarah.morrison said:
I do not accept that the fasting window is a minor inconvenience.

There is a second half to this that has not been said yet. Steady state is the thing most people miss. The terminal half-life is about a week, so every dose step takes four to five weeks to fully express itself. Judging a step at day ten is judging the ascent, not the plateau, and it is the single commonest reason people escalate before they needed to.

Last edited: Feb 3, 2026 at 3:03 PM
26 21Dr.LipidDallas, alex_tucson, kevin_tulsa and 23 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
robert_kc
Member
289
1,234
Oct 2024
Kansas City, MO
Feb 3, 2026 at 11:07 AM#9

One thing that is still open after Dr.SurgeonPGH’s answer:

Whether the fasting requirement is as strict in practice as the label implies, and what people actually see when they get it wrong?

25 20TomTeleRx, DoseLogDan, SleepFixSam and 22 others
Reply Quote Save Share Report
TrialNerd_Beth
Senior Member
2,345
11,234
Jan 2024
Bethesda, MD
Feb 3, 2026 at 9:04 PM#10

OP back with an update, since a thread like this is useless without one.

I moved the tablet to the moment I wake up rather than trying to fit it around breakfast, and the difference in the following weeks was obvious. It was a timing problem, not a dose problem.

49 24SleepFixSam, PurityPaulOR, MaxMetOK and 46 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register